Antisense & RNAi Therapeutics Market Size, Share & Trends Report

Antisense & RNAi Therapeutics Market Size, Share & Trends Analysis Report By Route of Administration (Pulmonary Delivery, Intravenous Injection), By Application (CVDs, Oncology), By Technology, And Segment Forecasts, 2019 - 2025

Report ID: 978-1-68038-805-3
Number of Pages: 161
Format: Electronic (PDF)

Historical Range: 2014 - 2017
Industry: Healthcare

Market Segmentation

Antisense & RNAi Therapeutics Technology Outlook (Revenue, USD Million, 2014 - 2025)
- RNA Interference
  - siRNA
  - miRNA
- Antisense RNA
Antisense & RNAi Therapeutics Application Outlook (Revenue, USD Million, 2014 - 2025)
- Oncology
- Cardiovascular
- Respiratory Disorders
- Renal Diseases
- Neurodegenerative Disorders
- Genetic Disorders
- Infectious Diseases
- Other
Antisense & RNAi Therapeutics Route of Administration Outlook (Revenue, USD Million, 2014 - 2025)
- Pulmonary Delivery
- Intravenous Injections
- Intradermal Injections
- Intraperitoneal Injections
- Topical Delivery
- Other Delivery Methods
Antisense & RNAi Therapeutics Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
  - North America Antisense & RNAi Therapeutics Market, by Technology
    - RNA Interference
      - siRNA
      - miRNA
    - Antisense RNA
  - North America Antisense & RNAi Therapeutics Market, by Application
    - Oncology
    - Cardiovascular
    - Respiratory Disorders
    - Renal Diseases
    - Neurodegenerative Disorders
    - Genetic Disorders
    - Infectious Diseases
    - Other
  - North America Antisense & RNAi Therapeutics Market, by Route of Administration
    - Pulmonary Delivery
    - Intravenous Injections
    - Intradermal Injections
    - Intraperitoneal Injections
    - Topical Delivery
    - Other Delivery Methods
  - The U.S.
    - U.S. Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
        
        siRNA
        
        miRNA
      - Antisense RNA
    - U.S. Antisense & RNAi Therapeutics Market, by Application
      - Oncology
      - Cardiovascular
      - Respiratory Disorders
      - Renal Diseases
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
      - Other
    - U.S. Antisense & RNAi Therapeutics Market, by Route of Administration
      - Pulmonary Delivery
      - Intravenous Injections
      - Intradermal Injections
      - Intraperitoneal Injections
      - Topical Delivery
      - Other Delivery Methods
  - Canada
    - Canada Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
        
        siRNA
        
        miRNA
      - Antisense RNA
    - Canada Antisense & RNAi Therapeutics Market, by Application
      - Oncology
      - Cardiovascular
      - Respiratory Disorders
      - Renal Diseases
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
      - Other
    - Canada Antisense & RNAi Therapeutics Market, by Route of Administration
      - Pulmonary Delivery
      - Intravenous Injections
      - Intradermal Injections
      - Intraperitoneal Injections
      - Topical Delivery
      - Other Delivery Methods
- Europe
  - Europe Antisense & RNAi Therapeutics Market, by Technology
    - RNA Interference
      - siRNA
      - miRNA
    - Antisense RNA
  - Europe Antisense & RNAi Therapeutics Market, by Application
    - Oncology
    - Cardiovascular
    - Respiratory Disorders
    - Renal Diseases
    - Neurodegenerative Disorders
    - Genetic Disorders
    - Infectious Diseases
    - Other
  - Europe Antisense & RNAi Therapeutics Market, by Route of Administration
    - Pulmonary Delivery
    - Intravenous Injections
    - Intradermal Injections
    - Intraperitoneal Injections
    - Topical Delivery
    - Other Delivery Methods
  - Germany
    - Germany Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
        
        siRNA
        
        miRNA
      - Antisense RNA
    - Germany Antisense & RNAi Therapeutics Market, by Application
      - Oncology
      - Cardiovascular
      - Respiratory Disorders
      - Renal Diseases
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
      - Other
    - Germany Antisense & RNAi Therapeutics Market, by Route of Administration
      - Pulmonary Delivery
      - Intravenous Injections
      - Intradermal Injections
      - Intraperitoneal Injections
      - Topical Delivery
      - Other Delivery Methods
  - U.K.
    - U.K. Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
        
        siRNA
        
        miRNA
      - Antisense RNA
    - U.K. Antisense & RNAi Therapeutics Market, by Application
      - Oncology
      - Cardiovascular
      - Respiratory Disorders
      - Renal Diseases
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
      - Other
    - U.K. Antisense & RNAi Therapeutics Market, by Route of Administration
      - Pulmonary Delivery
      - Intravenous Injections
      - Intradermal Injections
      - Intraperitoneal Injections
      - Topical Delivery
      - Other Delivery Methods
- Asia Pacific
  - Asia Pacific Antisense & RNAi Therapeutics Market, by Technology
    - RNA Interference
      - siRNA
      - miRNA
    - Antisense RNA
  - Asia Pacific Antisense & RNAi Therapeutics Market, by Application
    - Oncology
    - Cardiovascular
    - Respiratory Disorders
    - Renal Diseases
    - Neurodegenerative Disorders
    - Genetic Disorders
    - Infectious Diseases
    - Other
  - Asia Pacific Antisense & RNAi Therapeutics Market, by Route of Administration
    - Pulmonary Delivery
    - Intravenous Injections
    - Intradermal Injections
    - Intraperitoneal Injections
    - Topical Delivery
    - Other Delivery Methods
  - China
    - China Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
        
        siRNA
        
        miRNA
      - Antisense RNA
    - China Antisense & RNAi Therapeutics Market, by Application
      - Oncology
      - Cardiovascular
      - Respiratory Disorders
      - Renal Diseases
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
      - Other
    - China Antisense & RNAi Therapeutics Market, by Route of Administration
      - Pulmonary Delivery
      - Intravenous Injections
      - Intradermal Injections
      - Intraperitoneal Injections
      - Topical Delivery
      - Other Delivery Methods
  - Japan
    - Japan Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
        
        siRNA
        
        miRNA
      - Antisense RNA
    - Japan Antisense & RNAi Therapeutics Market, by Application
      - Oncology
      - Cardiovascular
      - Respiratory Disorders
      - Renal Diseases
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
      - Other
    - Japan Antisense & RNAi Therapeutics Market, by Route of Administration
      - Pulmonary Delivery
      - Intravenous Injections
      - Intradermal Injections
      - Intraperitoneal Injections
      - Topical Delivery
      - Other Delivery Methods
- Latin America
  - Latin America Antisense & RNAi Therapeutics Market, by Technology
    - RNA Interference
      - siRNA
      - miRNA
    - Antisense RNA
  - Latin America Antisense & RNAi Therapeutics Market, by Application
    - Oncology
    - Cardiovascular
    - Respiratory Disorders
    - Renal Diseases
    - Neurodegenerative Disorders
    - Genetic Disorders
    - Infectious Diseases
    - Other
  - Latin America Antisense & RNAi Therapeutics Market, by Route of Administration
    - Pulmonary Delivery
    - Intravenous Injections
    - Intradermal Injections
    - Intraperitoneal Injections
    - Topical Delivery
    - Other Delivery Methods
  - Brazil
    - Brazil Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
        
        siRNA
        
        miRNA
      - Antisense RNA
    - Brazil Antisense & RNAi Therapeutics Market, by Application
      - Oncology
      - Cardiovascular
      - Respiratory Disorders
      - Renal Diseases
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
      - Other
    - Brazil Antisense & RNAi Therapeutics Market, by Route of Administration
      - Pulmonary Delivery
      - Intravenous Injections
      - Intradermal Injections
      - Intraperitoneal Injections
      - Topical Delivery
      - Other Delivery Methods
- MEA
  - MEA Antisense & RNAi Therapeutics Market, by Technology
    - RNA Interference
      - siRNA
      - miRNA
    - Antisense RNA
  - MEA Antisense & RNAi Therapeutics Market, by Application
    - Oncology
    - Cardiovascular
    - Respiratory Disorders
    - Renal Diseases
    - Neurodegenerative Disorders
    - Genetic Disorders
    - Infectious Diseases
    - Other
  - MEA Antisense & RNAi Therapeutics Market, by Route of Administration
    - Pulmonary Delivery
    - Intravenous Injections
    - Intradermal Injections
    - Intraperitoneal Injections
    - Topical Delivery
    - Other Delivery Methods
  - South Africa
    - South Africa Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
        
        siRNA
        
        miRNA
      - Antisense RNA
    - South Africa Antisense & RNAi Therapeutics Market, by Application
      - Oncology
      - Cardiovascular
      - Respiratory Disorders
      - Renal Diseases
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
      - Other
    - South Africa Antisense & RNAi Therapeutics Market, by Route of Administration
      - Pulmonary Delivery
      - Intravenous Injections
      - Intradermal Injections
      - Intraperitoneal Injections
      - Topical Delivery
      - Other Delivery Methods

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2014 to 2025
Market estimates and forecast for product segments up to 2025
Regional market size and forecast for product segments up to 2025
Market estimates and forecast for application segments up to 2025
Regional market size and forecast for application segments up to 2025
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.